Baird Medical Investment Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Baird Medical Investment Holdings Limited (BDMD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income12.4510.5512.5711.687.10
Depreciation & Amortization1.511.381.471.411.07
Deferred Income Tax0.03-0.54-0.14-0.050.00
Stock Based Compensation0.000.000.000.090.00
Change in Working Capital-21.70-14.86-14.05-4.56-6.30
Change in Accounts Receivable-17.80-9.67-14.84-3.58-3.76
Change in Inventory-0.190.111.57-0.87-0.06
Change in Accounts Payable0.730.34-0.100.52-2.38
Change in Other Working Capital-6.90-4.49-2.60-0.470.18
Other Operating Activities0.18-0.310.06-1.001.66
Net Cash from Operating Activities-6.31-1.020.497.253.91
Investing Activities
Capital Expenditures-2.85-2.64-5.91-1.33-0.66
Sales/Maturities of Investments0.000.00-0.040.000.00
Other Investing Activities0.000.000.001.56-1.52
Net Cash from Investing Activities-2.85-2.64-5.920.24-2.17
Financing Activities
Debt Repayment-11.79-7.86-4.95-4.84-4.90
Common Stock Issued2.900.000.002.052.95
Common Stock Repurchased0.000.000.00-10.510.00
Dividends Paid0.000.000.00-5.430.00
Other Financing Activities-2.49-0.830.30-10.49-0.32
Net Cash from Financing Activities10.723.464.41-5.31-0.90
Summary
Effect of Forex Changes on Cash-0.090.00-0.300.020.00
Net Change in Cash1.46-0.20-1.322.180.84
Cash at Beginning of Period1.511.713.031.070.00
Cash at End of Period2.971.511.713.030.00
Free Cash Flow-9.17-3.66-5.425.923.25
Supplemental Disclosures
Interest Paid0.500.260.240.150.10
Income Taxes Paid1.842.641.443.481.02